Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women

被引:54
作者
Bednarek-Tupikowska, G [1 ]
Bohdanowicz-Pawlak, A [1 ]
Bidzinska, B [1 ]
Milewicz, A [1 ]
Antonowicz-Juchniewicz, J [1 ]
Andrzejak, R [1 ]
机构
[1] Med Univ, Dept Endocrinol & Diabet, PL-50367 Wroclaw, Poland
关键词
estradiol; lipid peroxides; glutathione peroxidase; superoxide dismutase;
D O I
10.1080/713602888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Free radical reactions are involved in processes connected with aging. Estradiol acts as antioxidant and free radical scavenger, but the mechanism of this action remains unknown. Estradiol has a hydroxyphenolic structure and may donate hydrogen atoms to lipid peroxyradicals to terminate chain reactions. There are a few reports concerning the influence of estradiol on natural antioxidant enzyme activity, such as superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT). The aim of this study ws to estimate the relationship between the levels of estradiol and lipid peroxide (LPO), a marker of membrane lipid peroxidation, and the correlation between estradiol and erythrocyte SOD and GSH-Px activity. The study included 13 premenopausal and 13 postmenopausal healthy women. Serum levels of estradiol, follicle-stimulating hormone (FSH) and LPO, and erythrocyte SOD and GSH-Px activity were estimated in all subjects. Premenopausal women revealed significantly higher estradiol levels and lower LPO concentrations, as well as significantly higher GSH-Px activity than the postmenopausal group. SOD activity did not differ between the two groups. There was a negative correlation between serum estradiol and LPO levels as well as a positive correlation between estradiol and GSH-Px activity. These results support the hypothesis that estradiol exerts its antioxidant action not only through its chemical structure but probably also through its inf hence on natural cellular antioxidant enzyme activity.
引用
收藏
页码:298 / 303
页数:6
相关论文
共 31 条
  • [1] Estradiol-17 beta as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants
    Ayres, S
    Tang, MY
    Subbiah, MTR
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (04): : 367 - 375
  • [2] ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN
    BARRETTCONNOR, E
    BUSH, TL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14): : 1861 - 1867
  • [3] BEDNAREKTUPIKOW.G, 2000, IN PRESS GIN POL
  • [4] BOHDANOWICZPAWL.A, 1995, POST MED KLIN DOSW, V4, P231
  • [5] Hormone replacement therapy and the skin
    Brincat, MP
    [J]. MATURITAS, 2000, 35 (02) : 107 - 117
  • [6] Effects of hormone therapy on bone mineral density - Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
    Bush, TL
    Wells, HB
    James, MK
    BarrettConnor, E
    Marcus, R
    Greendale, G
    Hunsberger, S
    McGowan, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17): : 1389 - 1396
  • [7] Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
    Chen, FP
    Lee, N
    Wang, CH
    Cherng, WJ
    Soong, YK
    [J]. FERTILITY AND STERILITY, 1998, 69 (02) : 267 - 273
  • [8] COLLINS P, 1997, MENOPAUSE REV, V2, P12
  • [9] Postmenopausal hormone therapy and mortality
    Grodstein, F
    Stampfer, MJ
    Colditz, GA
    Willett, WC
    Manson, JE
    Joffe, M
    Rosner, B
    Fuchs, C
    Hankinson, SE
    Hunter, DJ
    Hennekens, CH
    Speizer, FE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25) : 1769 - 1775
  • [10] HALLIWELL B, 1992, J LAB CLIN MED, V119, P598